Multiple organ dysfunction syndrome (MODS) is one of the most common syndromes of critical illness and the leading cause of mortality among critically ill patients. Multiple organ dysfunction syndrome is the clinical consequence of a dysregulated inflammatory response, triggered by clinically diverse factors with the main pillar of management being invasive organ support. During the last years, the advances in the clarification of the molecular pathways that trigger, mitigate, and determine the outcome of MODS have led to the increasing recognition of MODS as a distinct disease entity with distinct etiology, pathophysiology, and potential future therapeutic interventions. Given the lack of effective treatment for MODS, its early recognition, the early intensive care unit admission, and the initiation of invasive organ support remain the most effective strategies of preventing its progression and improving outcomes.
BariePSHydoLJ. Epidemiology of multiple organ dysfunction syndrome in critical surgical illness. Surg Infect. 2000;1(3):173–185.
2.
El-MenyarAAl ThaniHZakariaER, et al.Multiple organ dysfunction syndrome (MODS): is it preventable or inevitable. Int J Clin Med. 2012;3(7A):722–730.
3.
CieslaDJMooreEEJohnsonJLBurchJMCothrenCCSauaiaA. A 12-year prospective study of postinjury multiple organ failure: has anything changed?Arch Surg. 2005;140(5):432–438.
4.
FaistEBaueAEDittmerHHebererG. Multiple organ failure in polytrauma patients. J Trauma. 1983;23(9):775–787.
5.
AngusDCLinde-ZwirbleWTLidickerJClermontGCarcilloJPinskyMR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310.
6.
ChurpekMMZadraveczFJWinslowCHowellMDEdelsonDP. Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med. 2015;192(8):958–964.
7.
MayrVDDunserMWGreilV, et al.Causes of death and determinants of outcome in critically ill patients. Crit Care. 2006;10(6):R154. doi:10.1186/cc5086.
8.
VincentJLSakrYSprungCL, et al.Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–353.
9.
GiannoniCChelazziCVillaGDe GaudioAR. Organ dysfunction scores in ICU. Trends Anaesth Crit Care. 2013;3(3):89–96.
10.
TengLYuMLiJM, et al.Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection. Mol Cell Biochem. 2012;360(1-2):271–277.
11.
LiNSongZWangJ, et al.Prognostic value of natriuretic peptides in severe trauma patients with multiple organ dysfunction syndrome. Exp Ther Med. 2015;10(2):792–796.
12.
SugitaAKinoshitaKSakuraiA, et al.Systemic impact on secondary brain aggravation due to ischemia/reperfusion injury in post-cardiac arrest syndrome: a prospective observational study using high-mobility group box 1 protein. Crit Care. 2017;21(1):247.
13.
GuCQiaoWWang L LiMSongK. Identification of genes and pathways associated with multiple organ dysfunction syndrome by microarray analysis. Mol Med Rep. 2018;18(1):31–40.
14.
OivaJMustonenHKylänpääML, et al.Patients with acute pancreatitis complicated by organ failure show highly aberrant monocyte signaling profiles assessed by phospho-specific flow cytometry. Crit Care Med. 2010;38(8):1702–1708.
15.
McGhanLJJaroszewskiDE. The role of Toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation. Injury. 2012;43(2):129–136.
16.
UhligUHaitsmaJJGoldmannTPoelmaDLLachmannBUhligS. Ventilation-induced activation of the mitogen-activated protein kinase pathway. Eur Respir J. 2002;20(4):946–956.
17.
Di PaolaRGaluppoMMazzonEPaternitiIBramantiPCuzzocreaS. PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice. Pharmacol Res. 2010;61(2):175–187.
18.
AltemeierWAMatute-BelloGGharibSAGlennyRWMartinTRLilesWC. Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol. 2005;175(5):3369–3376.
19.
JabandzievPSmerekMMichalekJ, et al.Multiple gene-to-gene interactions in children with sepsis: a combination of five gene variants predicts outcome of life-threatening sepsis. Crit Care. 2014;18(1):R1. doi:10.1186/cc13174.
20.
GharibSAMarDBomsztykK, et al.System-wide mapping of activated circuitry in experimental systemic inflammatory response syndrome. Shock. 2016;45(2):148–156.
21.
MadáchKAladzsityISzilágyiÁ, et al.4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study. Crit Care. 2010;14(2):R79.
22.
ThiessenSEVan den BergheGVanhorebeekI. Mitochondrial and endoplasmic reticulum dysfunction and related defense mechanisms in critical illness-induced multiple organ failure. Biochim Biophys Acta Mol Basis Dis. 2017;1863(10):2534–2545.
23.
FinkMP.Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin. 2001;17(1):219–237.
24.
ZhengGLyuJHuangJXiangDXieMZengQ. Experimental treatments for mitochondrial dysfunction in sepsis: a narrative review. J Res Med Sci. 2015;20(2):185–195.
25.
SzabóCMódisK. Pathophysiological roles of peroxynitrite in circulatory shock. Shock. 2010;34(0 1):4–14.
26.
ProttiACarréJFrostMT, et al.Succinate recovers mitochondrial oxygen consumption in septic rat skeletal muscle. Crit Care Med. 2007;35(9):2150–2155.
27.
BrownleeM. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625.
28.
FredrikssonKHammarqvistFStrigardK, et al.Derangements in mitochondrial metabolism in inter- costal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab. 2006;291(5):1044–1050.
29.
CarreJEOrbanJCReL, et al.Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med. 2010;182(6):745–751.
30.
MalaisseWNadlABLadriereLZhangTM. Protective effects of succinic acid dimethyl ester infusion in experimental endotoxaemia. Nutrition. 1997;13(4):330–341.
31.
MiyajiTHuXYuenPS, et al.Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int. 2003;64(5):1620–1631.
32.
LowesDThottakamBMWebsterNRMurphyMPGalleyHF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med. 2008;45(11):1559–1565.
33.
PielDGruberPJWeinheimerCJ, et al.Mitochondrial resuscitation with exogenous cytochrome c in the septic heart. Crit Care Med. 2007;35(9):2120–2127.
34.
FauvelHMarchettiPObertG, et al.Protective effects of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats. Am J Respir Crit Care Med. 2002;165(4):449–455.
35.
DareAJPhillipsARHickeyAJ, et al.A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med. 2009;47(11):1517–1525.
36.
VinokurovMOstrovVYurinskayaM, et al.Recombinant human Hsp70 protects against lipoteichoic acid-induced inflammation manifestations at the cellular and organismal levels. Cell Stress Chaperones. 2012;17(1):89–101.
37.
WangYLShenHHChengPY, et al.17-DMAG, an HSP90 inhibitor, ameliorates multiple organ dysfunction syndrome via induction of HSP70 in endotoxemic rats. PLoS One. 2016;11(5):e0155583.
38.
ZengLDuJGuW, et al.Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma. Crit Care. 2015;19(1):6. doi:10.1186/s13054-014-0727-2.
39.
YangRTenhunenJTonnessenTI. HMGB1 and histones play a significant role in inducing systemic inflammation and multiple organ dysfunctions in severe acute pancreatitis. Int J Inflam. 2017. doi:10.1155/2017/1817564.
40.
GunstJ. Recovery from critical illness-induced organ failure: the role of autophagy. Crit Care. 2017;21(1):209.
41.
GunstJDereseIAertgeertsA, et al.Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness. Crit Care Med. 2013;41(1):182–194.
42.
ChungMTLeeYMShenHH, et al.Activation of autophagy is involved in the protective effect of 17β-oestradiol on endotoxaemia-induced multiple organ dysfunction in ovariectomized rats. J Cell Mol Med. 2017;21(12):3705–3717.
43.
NakahiraKHaspelJARathinamVA, et al.Autophagy proteins regulate innate immune responses by inhibiting NALP3 inflammasome-mediated mitochondrial DNA release. Nat Immunol. 2011;12(3):222–230.
44.
GalluzziLKeppOChanFKKroemerG. Necroptosis: mechanisms and relevance to disease. Annu Rev Pathol. 2017;12:103–130.
45.
CuiYLQiuLHZhouSY, et al.Necroptosis as a potential therapeutic target in multiple organ dysfunction syndrome. Oncotarget. 2017;8(34):56980–56990.
46.
RobinsonNGanesanRHegedűsCKovácsKKuferTAVirágL. Programmed necrotic cell death of macrophages: focus on pyroptosis, necroptosis, and parthanatos. Redox Biol. 2019;26:101239.
47.
GaoYLZhaiJHChaiYF. Recent advances in the molecular mechanisms underlying pyroptosis in sepsis. Mediators Inflamm. 2018. doi:10.1155/2018/5823823.
48.
CabreraCPMansonJShepherdJM, et al.Signatures of inflammation and impending multiple organ dysfunction in the hyperacute phase of trauma: a prospective cohort study. PLoS Med. 2017;14(7):e1002352.
49.
JunLINeng-pingLIYong-fengG, et al.Dynamic activity of NF-kB in multiple trauma patients and protective effects of ulinastain. Chin J Traumatol. 2011;14(6):354–358.
50.
UchidaMAbeTOnoKTamiyaN. Ulinastatin did not reduce mortality in elderly multiple organ failure patients: a retrospective observational study in a single center ICU. Acute Med Surg. 2018;5(1):90–97.
51.
ZhouJYangDLiuKHouLZhangW. Systematic review and meta-analysis of the protective effect of resveratrol on multiple organ injury induced by sepsis in animal models. Biomed Rep. 2019;10(1):55–62.
52.
BakopoulosAKapelouzouATsilimigrasDI, et al.Expression of Toll-like receptors (TLRs) in the lungs of an experimental sepsis mouse model. PLoS One. 2017;12(11):e0188050.
53.
LvYLiuQZhaoMJinYLuJ. Role of biphasic changes in splenic dendritic cell activity in a mouse model of multiple organ dysfunction syndrome. Int J Clin Exp Pathol. 2014;7(8):4720–4733.
54.
AndruszkowHFischerJSasseM, et al.Interleukin-6 as inflammatory marker referring to multiple organ dysfunction syndrome in severely injured children. Scand J Trauma Resusc Emerg Med. 2014;22:16.
55.
JafferUWadeRGGourlayT. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(3):161–175.
56.
MansonJColeEDe’AthHD, et al.Early changes within the lymphocyte population are associated with the development of multiple organ dysfunction syndrome in trauma patients. Crit Care. 2016;20(1):176.
57.
KirchhoffCBiberthalerPMutschlerWEFaistEJochumMZedlerS. Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a cohort study. Crit Care. 2009;13(3):R88.
58.
SapanHBPaturusiIIslamAA, et al.Interleukin-6 and interleukin-10 plasma levels and mRNA expression in polytrauma patients. Chin J Traumatol. 2017;20(6):318–322.
59.
LuanYYYinCFQinQH, et al.Effect of regulatory T cells on promoting apoptosis of T lymphocyte and its regulatory mechanism in sepsis. J Interferon Cytokine Res. 2015;35(12):969–980.
60.
HazeldineJNaumannDNTomanE, et al.Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: a prospective cohort study. PLoS Med. 2017;14(7):e1002338.
61.
HallMWKnatzNLVetterlyC, et al.Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011;37(3):525–532.
62.
KimHDarwishIMonroyMFProckopDJLilesWCKainKC. Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome. BMC Immunol. 2014;15:1.
63.
JiaWCaoLYangS, et al.Regulatory T cells are protective in systemic inflammation response syndrome induced by zymosan in mice. PLoS One. 2013;8(5):e64397.
64.
GaoYLLuBZhaiJH, et al.The parenteral vitamin C improves sepsis and sepsis-induced multiple organ dysfunction syndrome via preventing cellular immunosuppression. Mediators Inflamm. 2017;4024672. doi:10.1155/2017/4024672.
65.
GuoJTaoWTangDZhangJ. Th17/regulatory T cell imbalance in sepsis patients with multiple organ dysfunction syndrome: attenuated by high-volume hemofiltration. Int J Artif Organs. 2017;40(11):607–614.
66.
QiuPCuiXSunJWelshJNatansonCEichackerPQ. Anti-tumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysis. Crit Care Med. 2013;41(10):2419–2429.
67.
NamasRAAlmahmoudKMiQ, et al.Individual-specific principal component analysis of circulating inflammatory mediators predicts early organ dysfunction in trauma patients. J Crit Care. 2016;36:146–153.
68.
BomsztykKMarDAnD, et al.Experimental acute lung injury induces multi-organ epigenetic modifications in key angiogenic genes implicated in sepsis-associated endothelial dysfunction. Crit Care. 2015;19(1):225.
69.
WadaTJesminSGandoS, et al.Angiogenic factors and their soluble receptors predict organ dysfunction and mortality in post-cardiac arrest syndrome. Crit Care. 2012;16(5):R171.
70.
LinSMChungFTKuoCH, et al.Circulating angiopopietin-1 correlates with the clinical course of multiple organ dysfunction syndrome and mortality in patients with severe sepsis. Medicine (Baltimore). 2015;94(20):e878.
71.
CallJADonetJMartinKS, et al.Muscle-derived extracellular superoxide dismutase inhibits endothelial activation and protects against multiple organ dysfunction syndrome in mice. Free Radic Biol Med. 2017;113:212–223.
72.
ColettaCMódisKOláhG, et al.Endothelial dysfunction is a potential contributor to multiple organ failure and mortality in aged mice subjected to septic shock: preclinical studies in a murine model of cecal ligation and puncture. Crit Care. 2014;18(5):511.
73.
PengYGaoMJiangY, et al.Angiogenesis inhibitor endostatin protects mice with sepsis from multiple organ dysfunction syndrome. Shock. 2015;44(4):357–364.
LouisKNeteaMGCarrerDP, et al.Bacterial translocation in an experimental model of multiple organ dysfunctions. J Surg Res. 2013;183(2):686–694.
77.
MooreFAMooreEEPoggettiR, et al.Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991;31(5):629–636.
78.
SenthilMWatkinsABarlosD, et al.Intravenous injection of trauma-hemorrhagic shock mesenteric lymph causes lung injury that is dependent upon activation of the inducible nitric oxide synthase pathway. Ann Surg. 2007;246(5):822–830.
79.
BadamiCDSenthilMCaputoFJ, et al.Mesenteric lymph duct ligation improves survival in a lethal shock model. Shock. 2008;30(6):680–685.
80.
KlingensmithNJCoopersmithCM. The gut as the motor of multiple organ dysfunction in critical illness. Crit Care Clin. 2016;32(2):203–212.
81.
YosephBPKlingensmithNJLiangZ, et al.Mechanisms of intestinal barrier dysfunction in sepsis. Shock. 2016;46(1):52–59.
82.
ChengJWeiZLiuX, et al.The role of intestinal mucosa injury induced by intra-abdominal hypertension in the development of abdominal compartment syndrome and multiple organ dysfunction syndrome. Crit Care. 2013;17(6):R283.
83.
OsukaAKusukiHMatsuuraHShimizuKOguraHUeyamaM. Acute intestinal damage following severe burn correlates with the development of multiple organ dysfunction syndrome: a prospective cohort study. Burns. 2017;43(4):824–829.
84.
RoncoCTettaCMarianoF, et al.Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27(9):792–801.
85.
RimmerEHoustonBLKumarA, et al.The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care. 2014;18(6):699.
86.
NguyenTCHanYYKissJE, et al.Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008;36(10):2878–2887.
87.
KawaiYCornellTTCooleyEG, et al.Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support. Pediatr Crit Care Med. 2015;16(4):366.
88.
RajasekaranSKruseKKoveyK, et al.Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children. Pediatr Crit Care Med. 2014;15(5):401–408.
89.
ChangKSvabekCVazquez-GuillametC, et al.Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care. 2014;18(1):R3.
90.
BrahmamdamPInoueSUnsingerJChangKCMcDunnJEHotchkissRS. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J Leukoc Biol. 2010;88(2):233–240.
91.
InoueSBoLBianJUnsingerJChangKHotchkissRS. Dose-dependent effect of anti-CTLA-4 on survival in sepsis. Shock. 2011;36(1):38–44.
92.
LeeKCStadlbauerVJalanR. Extracorporeal liver support devices for listed patients. Liver Transpl. 2016;22(6):839–848.
93.
BañaresRNevensFLarsenFS, et al.Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57(3):1153–1162.
94.
KribbenAGerkenGHaagS, et al.Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142(4):782–789.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
